BI 894999

BI 894999 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 894999, covering 2024-04-15 to 2024-04-15. Get the full timeline:

Most recent: Clinical Trial Update: BI 894999 First in Human Dose Finding Study in Advanced Malignancies [Phase 1]